{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:39:43Z","timestamp":1794217183259,"version":"4.8.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>To review recent finding on MIC-1\/GDF15 and re-evaluate it as a potential target for the therapy of anorexia\/cachexia syndromes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>MIC-1\/GDF15 consistently induces anorexia\/cachexia in animal models. Its actions on brainstem feeding centers leads to anorexia, inducing prolonged undernutrition and consequent loss of both lean and fat mass. Epidemiological studies by multiple groups have linked substantially elevated serum levels of this cytokine to anorexia\/cachexia syndromes in diverse diseases such as cancer, chronic renal and cardiac failure, and chronic obstructive lung disease. These elevated serum levels are similar to those required to induce this syndrome in animals. Recent identifications of its previously elusive receptor as GFRAL, has enhanced understanding of its biology and suggests that modulating the MIC-1\/GDF15\u2013GFRAL pathway may be a therapeutic target for anorexia\/cachexia syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Inhibiting MIC-1\/GDF15 or its receptor GFRAL are high-value potential targets for treatment of anorexia\/cachexia syndrome in patients whose elevated serum levels may justify its use.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/spc.0000000000000384","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T23:43:20Z","timestamp":1534981400000},"page":"404-409","source":"Crossref","is-referenced-by-count":21,"title":["Targeting the divergent TGF\u03b2 superfamily cytokine MIC-1\/GDF15 for therapy of anorexia\/cachexia syndromes"],"prefix":"10.1097","volume":"12","author":[{"given":"Vicky Wang-Wei","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel N.","family":"Breit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230926","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R2-20230926","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm1677","article-title":"Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1","volume":"13","author":"Johnen","year":"2007","journal-title":"Nat Med"},{"key":"R3-20230926","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.07.018","article-title":"The MIC-1\/GDF15 - GFRAL pathway in energy homeostasis: implications for obesity, cachexia and other associated diseases","author":"Tsai","year":"2018","journal-title":"Cell Metab"},{"key":"R4-20230926","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the antiobesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat Med"},{"key":"R5-20230926","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat Med"},{"key":"R6-20230926","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat Med"},{"key":"R7-20230926","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Nonhomeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"key":"R8-20230926","doi-asserted-by":"crossref","first-page":"e100370","DOI":"10.1371\/journal.pone.0100370","article-title":"The anorectic actions of the TGF\u03b2 cytokine MIC-1\/GDF15 require an intact brainstem area postrema and nucleus of the solitary tract","volume":"9","author":"Tsai","year":"2014","journal-title":"PLoS One"},{"key":"R9-20230926","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0140-6736(02)09093-1","article-title":"Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study","volume":"359","author":"Brown","year":"2002","journal-title":"Lancet"},{"key":"R10-20230926","first-page":"4781","article-title":"The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women","volume":"85","author":"Moore","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20230926","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.ijrobp.2006.08.004","article-title":"Microarray analysis of radiation response genes in primary human fibroblasts","volume":"66","author":"Kis","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20230926","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1667\/RR3492.1","article-title":"Ionizing radiation enhances the expression of the nonsteroidal anti-inflammatory drug-activated gene (NAG1) by increasing the expression of TP53 in human colon cancer cells","volume":"165","author":"Okazaki","year":"2006","journal-title":"Radiat Res"},{"key":"R13-20230926","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.ijrobp.2012.02.013","article-title":"Strain-dependent damage in mouse lung after carbon ion irradiation","volume":"84","author":"Moritake","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-20230926","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ijrobp.2013.11.248","article-title":"Accurate gene expression-based biodosimetry using a minimal set of human gene transcripts","volume":"88","author":"Tucker","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-20230926","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/gfr575","article-title":"Macrophage inhibitory cytokine-1\u200a(MIC-1\/GDF15) and mortality in end-stage renal disease","volume":"27","author":"Breit","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R16-20230926","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000455907","article-title":"Association of growth differentiation factor 15 with mortality in a prospective hemodialysis cohort","volume":"7","author":"You","year":"2017","journal-title":"Cardiorenal Med"},{"key":"R17-20230926","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jacc.2007.04.091","article-title":"Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure","volume":"50","author":"Kempf","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R18-20230926","doi-asserted-by":"crossref","first-page":"1601298","DOI":"10.1183\/13993003.01298-2016","article-title":"Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD","volume":"49","author":"Huseb\u00f8","year":"2017","journal-title":"Eur Respir J"},{"key":"R19-20230926","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jcsm.12096","article-title":"Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo","volume":"7","author":"Patel","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R20-20230926","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.0530278100","article-title":"Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum","volume":"100","author":"Welsh","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-20230926","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/1055-9965.EPI-06-0841","article-title":"Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases","volume":"16","author":"Selander","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R22-20230926","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R23-20230926","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3892\/ol.2016.5183","article-title":"Growth differentiating factor-15 (GDF-15): a potential biomarker and therapeutic target for cancer-associated weight loss","volume":"12","author":"Lerner","year":"2016","journal-title":"Oncol Lett"},{"key":"R24-20230926","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"R25-20230926","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R26-20230926","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R27-20230926","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"R28-20230926","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1111\/febs.12253","article-title":"Mechanisms regulating skeletal muscle growth and atrophy","volume":"280","author":"Schiaffino","year":"2013","journal-title":"FEBS J"},{"key":"R29-20230926","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcdb.2015.11.002","article-title":"Protein breakdown in cancer cachexia","volume":"54","author":"Sandri","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"R30-20230926","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"R31-20230926","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MCO.0b013e3281a30594","article-title":"Risk factor paradox in wasting diseases","volume":"10","author":"Kalantar-Zadeh","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R32-20230926","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/bjc.2017.149","article-title":"Subcutaneous adiposity is an independent predictor of mortality in cancer patients","volume":"117","author":"Ebadi","year":"2017","journal-title":"Br J Cancer"},{"key":"R33-20230926","doi-asserted-by":"crossref","first-page":"e34868","DOI":"10.1371\/journal.pone.0034868","article-title":"Macrophage inhibitory cytokine 1\u200a(MIC-1\/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets","volume":"7","author":"Macia","year":"2012","journal-title":"PLoS One"},{"key":"R34-20230926","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ijo.2017.258","article-title":"Treatment with the TGF-b superfamily cytokine MIC-1\/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity","volume":"42","author":"Tsai","year":"2018","journal-title":"Int J Obes (Lond)"},{"key":"R35-20230926","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jcsm.12077","article-title":"MAP3K11\/GDF15 axis is a critical driver of cancer cachexia","volume":"7","author":"Lerner","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R36-20230926","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41467-018-03258-0","article-title":"Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum","volume":"9","author":"Fejzo","year":"2018","journal-title":"Nat Commun"},{"key":"R37-20230926","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.7314\/APJCP.2014.15.15.6047","article-title":"Weight loss correlates with macrophage inhibitory cytokine-1 expression and might influence outcome in patients with advanced esophageal squamous cell carcinoma","volume":"15","author":"Lu","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R38-20230926","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/thoraxjnl-2014-206225","article-title":"Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs","volume":"70","author":"Bloch","year":"2015","journal-title":"Thorax"},{"key":"R39-20230926","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.molmed.2017.10.005","article-title":"Targeting obesity and cachexia: identification of the GFRAL receptor-MIC-1\/GDF15 pathway","volume":"23","author":"Breit","year":"2017","journal-title":"Trends Mol Med"},{"key":"R40-20230926","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8732","article-title":"Long-acting MIC-1\/GDF15 molecules to treat obesity: evidence from mice to monkeys","volume":"9","author":"Xiong","year":"2017","journal-title":"Sci Transl Med"},{"key":"R41-20230926","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","article-title":"ROMANA 3: a phase 3 safety extension study of anamorelin in advanced nonsmall-cell lung cancer (NSCLC) patients with cachexia","volume":"28","author":"Currow","year":"2017","journal-title":"Ann Oncol"},{"key":"R42-20230926","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with nonsmall-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201812000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T07:14:55Z","timestamp":1695712495000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201812000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000384","relation":{},"ISSN":["1751-4258","1751-4266"],"issn-type":[{"value":"1751-4258","type":"print"},{"value":"1751-4266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}